--- title: "BECTON DICKINSON & CO (BDX) news: convertible notes" url: "https://aibio.space/companies/becton-dickinson/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BDX convertible notes news: BCAL Diagnostics details convertible note draws under its $10 million facility. BECTON DICKINSON & CO (NYSE: BDX), United States." --- BDX BECTON DICKINSON & CO NYSE · United States # BECTON DICKINSON & CO (BDX) news BDX convertible notes news Debt Financing · 2026-08-21 ## [BCAL Diagnostics details convertible note draws under its $10 million facility](https://aibio.space/news/bcal-diagnostics-details-convertible-note-draws-under-10-million/) After raising $3.1 million by February, BCAL drew further notes and plans more, which use up its Listing Rule 7.1 capacity. ## Latest BECTON DICKINSON & CO news We have not published a story on BECTON DICKINSON & CO yet. When there is news, it will appear here. ## BECTON DICKINSON & CO at a glance - **Ticker**: BDX - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $708.0 million ### Related companies - [Sensus Healthcare](https://aibio.space/companies/sensus-healthcare/) NASDAQ: SRTS - [BOSTON SCIENTIFIC CORP](https://aibio.space/companies/boston-scientific/) NYSE: BSX - [TFA Therapeutics](https://aibio.space/companies/tfa-therapeutics/) OTC: RAJAF - [BIOHARVEST SCIENCES INC.](https://aibio.space/companies/bioharvest-sciences/) NASDAQ: BHST - [20/20 Biolabs](https://aibio.space/companies/20-20-biolabs/) NASDAQ: AIDX - [IRIDEX CORP](https://aibio.space/companies/iridex/) NASDAQ: IRIX - [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) NASDAQ: LUCD - [PANACEA LIFE SCIENCES HOLDINGS, INC.](https://aibio.space/companies/panacea-life-sciences/) OTC: PLSH ### Also on NYSE - [REVVITY, INC.](https://aibio.space/companies/revvity/) RVTY - [SHOULDER INNOVATIONS, INC.](https://aibio.space/companies/shoulder-innovations/) SI - [MSA Safety](https://aibio.space/companies/msa-safety/) MSA - [Picard Medical](https://aibio.space/companies/picard-medical/) PMI - [STRYKER CORP](https://aibio.space/companies/stryker/) SYK - [BOSTON SCIENTIFIC CORP](https://aibio.space/companies/boston-scientific/) BSX ## BECTON DICKINSON & CO annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Revenue | [$21.84 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | [$20.18 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | | Research and development | [$1.26 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | [$1.19 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | | Net income (loss) | [$1.68 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | [$1.71 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | | Cash and equivalents | [$567.0 million](https://www.sec.gov/Archives/edgar/data/10795/000001079526000035/) | [$1.72 billion](https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $708.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about BECTON DICKINSON & CO Has BECTON DICKINSON & CO sold convertible notes? Our latest story on this, dated Aug 21, 2026: "BCAL Diagnostics details convertible note draws under its $10 million facility". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/bcal-diagnostics-details-convertible-note-draws-under-10-million/). What is the ticker symbol of BECTON DICKINSON & CO? BECTON DICKINSON & CO trades under the ticker BDX on NYSE. Where is BECTON DICKINSON & CO listed? BECTON DICKINSON & CO is listed on NYSE. Which country or territory is BECTON DICKINSON & CO listed under? Our directory records BECTON DICKINSON & CO under United States. Does aibio.space cover BECTON DICKINSON & CO? aibio.space lists BECTON DICKINSON & CO among 2,820 public biotech companies and publishes its news here as stories appear. What was BECTON DICKINSON & CO's revenue last year? $21.84 billion for the fiscal year ended Sep 30, 2025, as reported to the SEC. Is BECTON DICKINSON & CO profitable? BECTON DICKINSON & CO reported net income of $1.68 billion for the fiscal year ended Sep 30, 2025, per its annual report to the SEC. How much does BECTON DICKINSON & CO spend on research and development? $1.26 billion in the fiscal year ended Sep 30, 2025, per its annual report. How much cash does BECTON DICKINSON & CO have? $708.0 million in cash at Jun 30, 2026, per its 10-Q. What is the latest BECTON DICKINSON & CO (BDX) stock news? Our latest story on BECTON DICKINSON & CO, dated Aug 21, 2026: "BCAL Diagnostics details convertible note draws under its $10 million facility". After raising $3.1 million by February, BCAL drew further notes and plans more, which use up its Listing Rule 7.1 capacity. [Source](https://aibio.space/news/bcal-diagnostics-details-convertible-note-draws-under-10-million/). How can I follow BECTON DICKINSON & CO (BDX) news? Press Follow on this page to add BECTON DICKINSON & CO to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming BECTON DICKINSON & CO so far, in Debt Financing. ## Investor discussion: BECTON DICKINSON & CO Members talk about BECTON DICKINSON & CO (BDX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:BDX on TradingView](https://www.tradingview.com/symbols/NYSE-BDX/). ## Listing details BECTON DICKINSON & CO is a public biotech or pharmaceutical company listed on NYSE under the ticker BDX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: BECTON DICKINSON & CO - **Ticker**: BDX - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/becton-dickinson/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "BECTON DICKINSON & CO (BDX) news: convertible notes", 2026-10-31, https://aibio.space/companies/becton-dickinson/